Tag: drug development
Insilico and SK Biopharm ink $2.5 billion AI drug discovery deal
The partnership targets neuroimmune and CNS disorders using Insilico's Pharma.AI engine, with $18 million in upfront payments and milestone-based upside.
Bigger AI models don’t always win in drug metabolism prediction
The OpenADMET challenge found that smaller, specialized models matched or beat large foundation models at predicting how the body processes…
OpenAI launches GPT-Rosalind for life sciences research
The frontier reasoning model is designed to accelerate drug discovery and biological research across chemistry, protein engineering, and genomics.
AI-powered biosimulation shakes up animal drug testing
Digital twins and multi-agent virtual scientists are accelerating the FDA's push to reduce animal testing.